Gessler M - Search Results

1

Mutually exclusive BCOR internal tandem duplications and YWHAE-NUTM2 fusions in clear cell sarcoma of kidney: not the full story.

Kenny C, Bausenwein S, Lazaro A, Furtwängler R, Gooskens SL, van den Heuvel Eibrink M, Vokuhl C, Leuschner I, Graf N, Gessler M, O'Sullivan MJ. Kenny C, et al. Among authors: gessler m. J Pathol. 2016 Apr;238(5):617-20. doi: 10.1002/path.4693. J Pathol. 2016. PMID: 27000436

2

Chibby, a novel antagonist of the Wnt pathway, is not involved in Wilms tumor development.

Zirn B, Wittmann S, Graf N, Gessler M. Zirn B, et al. Among authors: gessler m. Cancer Lett. 2005 Mar 18;220(1):115-20. doi: 10.1016/j.canlet.2004.08.001. Cancer Lett. 2005. PMID: 15737694

3

All-trans retinoic acid treatment of Wilms tumor cells reverses expression of genes associated with high risk and relapse in vivo.

Zirn B, Samans B, Spangenberg C, Graf N, Eilers M, Gessler M. Zirn B, et al. Among authors: gessler m. Oncogene. 2005 Aug 4;24(33):5246-51. doi: 10.1038/sj.onc.1208725. Oncogene. 2005. PMID: 15897880

4

Expression profiling of Wilms tumors reveals new candidate genes for different clinical parameters.

Zirn B, Hartmann O, Samans B, Krause M, Wittmann S, Mertens F, Graf N, Eilers M, Gessler M. Zirn B, et al. Among authors: gessler m. Int J Cancer. 2006 Apr 15;118(8):1954-62. doi: 10.1002/ijc.21564. Int J Cancer. 2006. PMID: 16287080

5

Target genes of the WNT/beta-catenin pathway in Wilms tumors.

Zirn B, Samans B, Wittmann S, Pietsch T, Leuschner I, Graf N, Gessler M. Zirn B, et al. Among authors: gessler m. Genes Chromosomes Cancer. 2006 Jun;45(6):565-74. doi: 10.1002/gcc.20319. Genes Chromosomes Cancer. 2006. PMID: 16575872

6

Loss of 11q and 16q in Wilms tumors is associated with anaplasia, tumor recurrence, and poor prognosis.

Wittmann S, Zirn B, Alkassar M, Ambros P, Graf N, Gessler M. Wittmann S, et al. Among authors: gessler m. Genes Chromosomes Cancer. 2007 Feb;46(2):163-70. doi: 10.1002/gcc.20397. Genes Chromosomes Cancer. 2007. PMID: 17099873

7

New prognostic markers revealed by evaluation of genes correlated with clinical parameters in Wilms tumors.

Wittmann S, Wunder C, Zirn B, Furtwängler R, Wegert J, Graf N, Gessler M. Wittmann S, et al. Among authors: gessler m. Genes Chromosomes Cancer. 2008 May;47(5):386-95. doi: 10.1002/gcc.20544. Genes Chromosomes Cancer. 2008. PMID: 18260125

8

WTX inactivation is a frequent, but late event in Wilms tumors without apparent clinical impact.

Wegert J, Wittmann S, Leuschner I, Geissinger E, Graf N, Gessler M. Wegert J, et al. Among authors: gessler m. Genes Chromosomes Cancer. 2009 Dec;48(12):1102-11. doi: 10.1002/gcc.20712. Genes Chromosomes Cancer. 2009. PMID: 19760609

9

Subtype-specific FBXW7 mutation and MYCN copy number gain in Wilms' tumor.

Williams RD, Al-Saadi R, Chagtai T, Popov S, Messahel B, Sebire N, Gessler M, Wegert J, Graf N, Leuschner I, Hubank M, Jones C, Vujanic G, Pritchard-Jones K; Children's Cancer and Leukaemia Group; SIOP Wilms' Tumour Biology Group. Williams RD, et al. Among authors: gessler m. Clin Cancer Res. 2010 Apr 1;16(7):2036-45. doi: 10.1158/1078-0432.CCR-09-2890. Epub 2010 Mar 23. Clin Cancer Res. 2010. PMID: 20332316 Free PMC article.

10

Multicenter study identified molecular blood-born protein signatures for Wilms Tumor.

Schmitt J, Heisel S, Keller A, Leidinger P, Ludwig N, Habel N, Furtwängler R, Nourkami-Tutdibi N, Wegert J, Grundy P, Gessler M, Graf N, Lenhof HP, Meese E. Schmitt J, et al. Among authors: gessler m. Int J Cancer. 2012 Aug 1;131(3):673-82. doi: 10.1002/ijc.26419. Epub 2011 Oct 23. Int J Cancer. 2012. PMID: 21913182

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

192 results

Search Page

Filters